Neuroendocrine Tumors of the Pancreas Grade 2 with Ki-67 Index More Than 5% and with Expression Cytokeratin 19 are the Risk Group of Rapid Progression

被引：0
|
作者：
Gurevich, L. [1 ]
Korsakova, N. [2 ]
Kazantseva, I. [2 ]
Egorov, A. [3 ]
Britvin, T. [2 ]
Vasilev, I [3 ]
机构：
[1] MF Vladimirsky Moscow Reg Res Clin Inst, Moscow, Russia
[2] Vladimirsky Moscow Reg Res Clin Inst, Moscow, Russia
[3] Moscow State Med Univ, Moscow, Russia
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
pancreas; neuroendocrine tumors; risk factors; ki-67; cytokeratin; 19;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G9
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [41] Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)
    Roquin, Guillaume
    Baudin, Eric
    Lombard-Bohas, Catherine
    Cadiot, Guillaume
    Dominguez, Sophie
    Guimbaud, Rosine
    Niccoli, Patricia
    Legoux, Jean-Louis
    Mitry, Emmanuel
    Rohmer, Vincent
    Ruszniewski, Philippe
    Walter, Thomas
    Ducreux, Michel
    Couvelard, Anne
    Scoazec, Jean-Yves
    Ramond-Roquin, Aline
    Caroli-Bosc, Francois-Xavier
    Hentic, Olivia
    NEUROENDOCRINOLOGY, 2018, 106 (01) : 38 - 46
  • [42] A Consenus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophaegal Adenocarcinoma
    Lee, Christina
    Hayat, Umar
    Song, Kevin
    Gravely, Amy A.
    Mesa, Hector
    Peltola, Justin
    Iwamoto, Carlos
    Manivel, Carlos
    Bilal, Mohammad
    Shaheen, Nicholas
    Shaukat, Aasma
    Hanson, Brian J.
    DISEASES OF THE ESOPHAGUS, 2023, 36 (03)
  • [43] Combination of Ki-67, MCM2, p16, and p53 Expression Can Distinguish High Grade Serous Carcinoma From Low Grade Serous Tumors
    Kelting, Sarah M.
    Paquette, Cherie
    Smolkin, Mark E.
    Jazaeri, Amir A.
    Barrett, Megan R.
    Stoler, Mark H.
    LABORATORY INVESTIGATION, 2016, 96 : 291A - 291A
  • [44] Combination of Ki-67, MCM2, p16, and p53 Expression Can Distinguish High Grade Serous Carcinoma From Low Grade Serous Tumors
    Kelting, Sarah M.
    Paquette, Cherie
    Smolkin, Mark E.
    Jazaeri, Amir A.
    Barrett, Megan R.
    Staler, Mark H.
    MODERN PATHOLOGY, 2016, 29 : 291A - 291A
  • [45] Degree of PgR expression is a more potent prognostic factor than Ki67 labeling index in ER-positive and HER2-negative breast cancer
    Kurozumi, S.
    Matsumoto, H.
    Hayashi, Y.
    Kurosumi, M.
    Toduka, K.
    Kubo, K.
    Nagai, E. S.
    Inoue, K.
    Horiguchi, J.
    Takeyoshi, I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S193 - S193
  • [46] Immunohistochemical evaluation of p16, MCM-2, and Ki-67 expression as markers of tumor progression in GISTs by tissue microarray and correlation with the risk classification of the NIH conference consensus
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 333 - 333
  • [47] Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence
    Liu, Xiaohai
    Feng, Ming
    Zhang, Ye
    Dai, Congxin
    Sun, Bowen
    Bao, Xinjie
    Deng, Kan
    Yao, Yong
    Wang, Renzhi
    WORLD NEUROSURGERY, 2018, 113 : E213 - E221
  • [48] Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2
    Zhao, Chaohui Lisa
    Dabiri, Bahram
    Hanna, Iman
    Lee, Lili
    Xiaofei Zhang
    Hossein-Zadeh, Zarrin
    Cao Wenqing
    Allendorf, John
    Rodriguez, Alex Pipas
    Weng, Katherine
    Turunbedu, Solomon
    Boyd, Adrienne
    Gupta, Mala
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 65
  • [49] A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophageal Adenocarcinoma (vol 36, doac065, 2023 )
    Lee, Christina
    Hayat, Umar
    Song, Kevin
    Gravely, Amy A.
    Mesa, Hector
    Peltola, Justin
    Iwamoto, Carlos
    Manivel, Carlos
    Bilal, Mohammad
    Shaheen, Nicholas
    Shaukat, Aasma
    Hanson, Brian J.
    DISEASES OF THE ESOPHAGUS, 2023, 36 (08)
  • [50] Consenus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophaegal Adenocarcinoma (Vol 00, Pg 1, Yr 2023)
    Lee, Christina
    Hayat, Umar
    Song, Kevin
    Gravely, Amy A.
    Mesa, Hector
    Peltola, Justin
    Iwamoto, Carlos
    Manivel, Carlos
    Bilal, Mohammad
    Shaheen, Nicholas
    Shaukat, Aasma
    Hanson, Brian J.
    DISEASES OF THE ESOPHAGUS, 2023, 36 (07)
12345